Global Elastomeric Infusion Pumps Market Analysis
IV medications such as local anesthetics, vaccines, and anti-neoplastic are administered using elastomeric infusion pumps, commonly known as disposable balloon pumps. In single infusions, these non-electronic, non-gravity-guided instruments are used. Elastomeric infusion pumps have a drug-filled stretchable balloon tank, and pressure from the elastic walls forces fluid distribution with a relatively constant pressure before the infusion reaches its limit.
By the end of 2027, the global elastomeric infusion pumps market is expected to be worth US$ 1,595.0 million.
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-sample/3129
The infusion of analgesics by plastic infusion pumps is used to relieve post-operative pain in procedures such as complete knee replacement and total hip replacement. As a result, the global elastomeric infusion pumps market is projected to expand at a faster rate during the forecast period due to an increase in the number of orthopedic procedures and surgeries. According to the American Academy of Orthopedic Surgeons’ 2018 Annual Report, the American Joint Replacement Registry has over 1 million cases and 1.4 million hip and knee arthroplasty operations.
Furthermore, elastomeric infusion pumps are less expensive and have fewer side effects than mechanical infusion pumps, increasing their use in ambulatory chemotherapy infusion centers. Since elastomeric infusion pumps do not require energy to function, there is no chance of drugs flowing freely to patients. Elastomeric infusion pumps are expected to increase in popularity due to their advantages over electric infusion pumps.
In terms of value, North America dominated the global elastomeric infusion pumps market in 2018, contributing about 33.0 percent market share, led by Asia Pacific.
The price of elastomeric infusion pumps varies greatly depending on the form of pump. Pumps that prescribe antibiotics are relatively inexpensive, while pumps that administer pain relievers are relatively expensive, costing between US$ 160 and US$ 450. Over the forecast period, such a scenario is expected to stifle growth of the global elastomeric infusion pumps market.
Furthermore, the market is expected to be hampered by strict legislation about the use of plastics in elastomeric infusion pumps. In sections of elastomeric infusion pumps, the European Commission and the US FDA issued safety evaluations of medical devices containing Di (2-ethylhexyl) phthalate (DEHP) and plasticized polyvinylchloride (PVC). Hence, manufacturers must concentrate on proper product safety labelling in order to prevent serious side effects, especially in the neonatal patient population.
Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/3129
In compact regional anesthesia, elastomeric infusion pumps may be used. Several studies have also shown that using an elastomeric infusion system after shoulder surgery helps patients to be discharged safely and quickly with less need for parenteral opiate analgesia. Furthermore, ambulatory treatment centers, dental care units, and cancer care centers in the United States are increasingly using elastomeric infusion pumps in portable regional anesthesia, which is expected to provide attractive growth prospects for market participants.
Furthermore, the rising use of elastomeric infusion pumps for chemotherapy drug administration in ambulatory treatment centers and at home is expected to provide substantial growth opportunities for market players. The use of elastomeric infusion pumps helps to reduce chemotherapy medication wastage, which helps to lower treatment costs.
The global elastomeric infusion pumps market was estimated at US$ 515.1 million in 2018 and is expected to hit US$ 1,095.1 million by 2027, with a CAGR of 8.8 percent between 2019 and 2027.
A recent trend in the market is increased R&D for novel applications of elastomeric infusion pumps. Researchers from the University Hospital of Lausanne in Switzerland evaluated the use of two sub-muscular catheters attached to two elastomeric pumps in postoperative continuous wound infiltration of levobupivacaine in September 2018.
Furthermore, the use of elastomeric infusion pumps for outpatient parenteral antimicrobial therapy is expected to drive growth of the global elastomeric infusion pumps market. A research published in the Journal of Antimicrobial Chemotherapy in 2018 found that using elastomeric infusion pumps, continuous infusions of flucloxacillin, cefepime, vancomycin, and piperacillin/tazobactam are useful in outpatient parenteral antimicrobial therapy.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/elastomeric-infusion-pumps-market-to-surpass-us-10951-million-by-2027-2530
Key players in the market need to focus on the effects of temperature, fill volume, and diluent on flow rates in elastomeric infusion pumps. Proper labelling of flow rates and monitoring of models as per desired infusion time is also important while production of the infusion pumps.
The market’s major players are concentrating their efforts on combining elastomeric infusion pumps with other digital innovations. In April 2017, B. Braun Medical Inc. combined the Easypump ST/LT Elastomeric Infusion Pump System with an interactive app that provides physicians and patients with informative material on the safe use and functionality of the Easypump for short- and long-term home infusion therapy.
Key companies contributing in the global elastomeric infusion pumps market are S.A.U, Leventon, B. Braun Melsungen AG, Halyard Health, Nipro Corporation, Fresenius Kabi, Baxter International Inc., and Ambu A/S.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027